24
Views
0
CrossRef citations to date
0
Altmetric
Practice Pearl

Reducing Cardiac Ischemic Events in Patients with ACS: Prasugrel versus Clopidogrel

, MD & , MD
Pages 198-200 | Published online: 13 Mar 2015

References

  • . Wiviott SD, Braunwald E, McCabe CH,. Prasugrel versus clopidogrel in patients with acute coronary syndromes. N Engl J Med. 2007;357(20):2001–2015
  • . Yusuf S, Zhao F, Mehta SR; Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial Investigators. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med. 2001;345(7):494–502
  • . Angiolillo DJ, Guzman LA, Bass TA. Current antiplatelet therapies: benefits and limitations. Am Heart J. 2008;156(2):3S–9S
  • . Mobley JE, Bresee SJ, Wortham DC, Craft RM, Snider CC, Carroll RC. Frequency of nonresponse antiplatelet activity of clopidogrel during pretreatment for cardiac catheterization. Am J Cardiol. 2004;93(4):456–458
  • . Angiolillo DJ, Fernandez OA, Bernardo E,. Variability in individual responsiveness to clopidogrel: clinical implications, management, and future perspectives. J Am Coll Cardiol. 2007;49(14):1505–1516
  • . Bhatt DL. Prasugrel in clinical practice. N Engl J Med. 2009;361(10):940–942
  • . Mega JL, Close SL, Wiviott SD,. Cytochrome p-450 polymorphisms and response to clopidogrel. N Engl J Med. 2009;360(4):354–362

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.